The most likely assumption is that the increase in D-dimer levels in COVID-19 patients is due to local, extravascular activity of the fibrinolytic system in the lungs and may not reflect the degree of activation of plasminogen and fibrinolysis occurring in tissues [448,449]. This evidence concerns the gene PLG and COVID-19.